Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01216163 · ClinicalTrials.gov registry record · Phase 3
Study Evaluating A Novel Ibuprofen Formulation In The Treatment Of Dental Pain
A Phase 3 study of Pain, sponsored by Pfizer.
- Completed
- Registry status
- Phase 3
- Development phase
- 218
- Enrollment target
- 1
- Study location
NCT01216163 is a Phase 3 study of Pain that has completed, run by Pfizer. The registered enrollment target is 218 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (28% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01216163, a Phase 3 study of Pain, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 218 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will compare the analgesic efficacy of a single-dose of a novel ibuprofen formulation to placebo and acetaminophen in the treatment of post-surgical dental pain following "wisdom" tooth (third molar) removal.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Acetaminophen
- DRUG Novel Ibuprofen
Study Locations (1)
Utah
- Pfizer Investigational Site - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 218 participants |
| Start Date | 2010-10 |
| Est. Completion | 2011-01 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01216163
The ClinicalTrials.gov registry entry for NCT01216163 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 218 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 304-participant average among 374 other Pain trials with a reported enrollment target (28% lower). The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pain appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.
NCT01216163 reports 1 study location spanning 1 distinct geographic area - top geographies include Utah.
Frequently Asked Questions
What is clinical trial NCT01216163 about?
NCT01216163 is a clinical study titled "Study Evaluating A Novel Ibuprofen Formulation In The Treatment Of Dental Pain". This study will compare the analgesic efficacy of a single-dose of a novel ibuprofen formulation to placebo and acetaminophen in the treatment of post-surgical dental pain following "wisdom" tooth (third molar) removal.
What is the current status of trial NCT01216163?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 218 participants. The study started on 2010-10. Estimated completion is 2011-01.
What conditions does trial NCT01216163 study?
This clinical trial studies the following conditions: Pain.
What interventions are being tested in trial NCT01216163?
The interventions under investigation include: Placebo (DRUG), Acetaminophen (DRUG), Novel Ibuprofen (DRUG).
Who is sponsoring clinical trial NCT01216163?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01216163 being conducted?
This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effect of NSAIDs on Union, Opioid Utilization and Pain Management for Tibia Fractures: A Pragmatic, Randomized Controlled Trial
RECRUITING · Phase 3
-
Opioid-Free Orthopaedics
RECRUITING · Phase 3
-
Suzetrigine in Total Hip Arthroplasty
RECRUITING · Phase 3
-
Optimizing Chronic Pain Care With Mindfulness and Chronic Pain Management Visits
RECRUITING · Phase 3
-
Implementation and Effectiveness of Mindfulness Oriented Recovery Enhancement as an Adjunct to Methadone Treatment
RECRUITING · Phase 3
-
Post-Op Pain Control for Prophylactic Intramedullary Nailing.
RECRUITING · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.